Natural inhibitors of cholinesterases: Implications for adverse drug reactions

Canadian Journal of Anaesthesia

Volumn 44, Issue 5, 1997, Pages 525-534

  Krasowski, Matthew D ^a   McGehee, Daniel S ^a   Moss, Jonathan ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; COCAINE; ENZYME INHIBITOR; GLYCOALKALOID; MIVACURIUM; PLANT EXTRACT; STEROID; SUXAMETHONIUM; UNCLASSIFIED DRUG;

ADVERSE DRUG REACTION; ALLELE; DRUG ACTIVITY; DRUG METABOLISM; ENZYME INHIBITION; EVOLUTION; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030808045     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03011943     Document Type: Review

References (69)

1. Cooper JR. Unsolved problems in the cholinergic nervous system. J Neurochem 1994; 63: 395-9.
2. Stewart DJ, Inaba T, Tang BK, Kalow W. Hydrolysis of cocaine in human plasma by cholinesterase. Life Sci 1977; 20: 1557-63.
3. Lockridge O, Mottershaw-Jackson N, Eckerson HW, LaDu BN. Hydrolysis of diacetylmorphine (heroin) by human serum cholinesterase. J Pharmacol Exp Ther 1980; 215: 1-8.
4. Hodgkin WE, Giblett ER, Levine H, Bauer W, Motulsky AG. Complete pseudocholinesterase deficiency: genetic and immunologic characterization. J Clin Invest 1965; 44: 486-97.
5. Cook DR, Stiller RL, Weakly JN, Chakravorty S, Brandom BW, Welch RM. In vitro metabolism of mivacurium chloride (BW B1090U) and succinylcholine. Anesth Analg 1989; 68: 452-6.
6. Petersen RS, Bailey PL, Kalameghan R, Ashwood ER. Prolonged neuromuscular block after mivacurium. Anesth Analg 1993; 76: 194-6.
7. McGuire MC, Nogueira CP, Bartels CF, et al. Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase. Proc Natl Acad Sci USA 1989; 86: 953-7.
8. Kalow W, Genest K. A method for the detection of atypical forms of human serum cholinesterase. Determination of dibucaine numbers. Can J Biochem Physiol 1957; 35: 339-46.
9. Viby-Mogensen J, Hanel HK. Prolonged apnoea after suxamethonium. An analysis of the first 225 cases reported to the Danish Cholinesterase Research Unit. Acta Anaesthesiol Scand 1978; 22: 371-80.
10. Erkola O, Rautoma P, Meretoja OA. Mivacurium when preceded by pancuronium becomes a long-acting muscle relaxant. Anesthesiology 1996; 84: 562-5.
11. Konkol RJ, Murphey LJ, Ferriero DM, Dempsey DA, Olsen GD. Cocaine metabolites in the neonate: potential for toxicity. J Child Neurol 1994; 9: 242-8.
12. Simone C, Derewlany LO, Oskamp M, Johnson D, Knie B, Koren G. Acetylcholinesterase and butyrylcholinesterase activity in the human term placenta: implications for fetal cocaine exposure. J Lab Clin Med 1994; 123: 400-6.
13. Ehrlich G, Viegas-Pequignot E, Ginzberg D, Sindel L, Soreq H, Zakut H. Mapping the human acetylcholinesterase gene to chromosome 7q22 by fluorescent in situ hybridization coupled with selective PCR amplification from a somatic hybrid cell panel and chromosome-sorted DNA libraries. Genomics 1992; 13: 1192-7.
14. Getman DK, Eubanks JH, Camp S, Evans GA, Taylor P. The human gene encoding acetylcholinesterase is located on the long arm of chromosome 7. Am J Hum Genet 1992; 51: 170-7.
15. Allderdice PW, Gardner HAR, Galutira D, Lockridge O, LaDu BN, McAlpine PJ. The cloned butyrylcholinesterase (BCHE) gene maps to a single chromosome site, 3q26. Genomics 1991; 11: 452-4.
16. Gnatt A, Prody CA, Zamir R, Lieman-Hurwitz J, Zakut H, Soreq H. Expression of alternatively terminated unusual human butyrylcholinesterase messenger RNA transcripts, mapping to chromosome 3q26-ter, in nervous system tumors. Cancer Res 1990; 50: 1983-7.
17. Hall LAC, Malcolm CA. The acetylcholinesterase gene of Anopheles stephensi. Cell Mol Neurobiol 1991; 11: 131-41.
18. Toutant JP, Massoulié J, Bon S. Polymorphism of pseudocholinesterase in Torpedo marmorata tissues: comparative study of the catalytic and molecular properties of this enzyme with acetylcholinesterase. J Neurochem 1985; 44: 580-92.
19. Taylor P. The cholinesterases. J Biol Chem 1991; 266: 4025-8.
20. Whittaker M. Cholinesterase. In: L Beckman (Eds.). Monographs in Human Genetics. Basel: Karger, 1986: 45-85.
21. Schwarz M, Glick D, Loewenstein Y, Soreq H. Engineering of human cholinesterases explains and predicts diverse consequences of administration of various drugs and poisons. Pharmacol Ther 1995; 67: 283-322.
22. Neville LF, Gnatt A, Loewenstein Y, Seidman S, Ehrlich G, Soreq H. Intramolecular relationships in cholinesterases revealed by oocyte expression of site-directed and natural variants of human BCHE. EMBO J 1992; 11: 1641-9.
23. Carmichael WW. The toxins of cyanobacteria. Sci Am 1994; 270: 78-86.
24. Hersh LB. Inhibition of aminopeptidase and acetylcholinesterase by puromycin and puromycin analogs. J Neurochem 1981; 36: 1594-6.
25. Ames BN, Profet M, Gold LS. Dietary pesticides (99.99% all natural). Proc Natl Acad Sci, USA 1990; 87: 7777-81.
26. Feldman PL, James MK, Brackeen MF, et al. Design, synthesis, and pharmacological evaluation of ultrashort-to long-acting opioid analgetics. J Med Chem 1991; 34: 2202-8.
27. Glass PSA, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (G187084B). Anesth Analg 1993; 77: 1031-40.
28. Dershwitz M, Hoke JF, Rosow CE, et al. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 1996; 84: 812-20.
29. Sinden SL, Deahl KL, Aulenbach B. Effect of glycoalkaloids and phenolics on potato flavor. J Food Sci 1976; 41: 520-3.
30. Bushway RJ, Ponnampalam R. α-chaconine and α-solanine content of potato products and their stability during several modes of cooking. Journal of Agricultural and Food Chemistry 1981; 29: 814-7.
31. Harris FW, Cockburn T. Alleged poisoning by potatoes. Analyst 1918; 43: 133-7.
32. Morris SC, Lee TH. The toxicity and teratogenicity of Solanaceae glycoalkaloids, particularly those of the potato (Solanum tuberosum): a review. Food Technology in Australia 1984; 36: 118-24.
33. Hansen A. Two fatal cases of potato poisoning. Science 1925; 61: 340-1.
34. McMillan M, Thompson JC. An outbreak of suspected solanine poisoning in schoolboys: examinations of criteria of solanine poisoning. Quarterly Journal of Medicine 1979; 48: 227-43.
35. Hellenäs K-E, Nyman A, Slanina P, Lööf L, Gabrielsson J. Determination of potato glycoalkaloids and their algycone in blood serum by high-performance liquid chromatography. Application to pharmacokinetic studies in humans. J Chromatogr 1992; 573: 69-78.
36. Willard M. Potato processing: past, present and future. American Potato Journal 1993; 70: 405-18.
37. Hopkins J. The glycoalkaloids: naturally of interest (but a hot potato?). Food Chem Toxicol 1995; 33: 323-39.
38. Slanina P. Solanine (glycoalkaloids) in potatoes: toxicological evaluation. Food Chem Toxicol 1990; 28: 759-61.
39. Jadhav SJ, Sharma RP, Salunkhe DK. Naturally occurring toxic alkaloids in foods. Crit Rev Toxicol 1981; 9: 21-104.
40. Azim A, Shaikh HA, Ahmad R. Effect of feeding greened potatoes on different visceral organs and blood plasma of rabbits. Journal of the Science of Food and Agriculture 1982; 33: 1275-9.
41. Nishie K, Gumbmann MR, Keyl AC. Pharmacology of solanine. Toxicol Appl Pharmacol 1971; 19: 81-92.
42. 3H-α-chaconine. Res Commun Chem Pathol Pharmacol 1976; 13: 161-71.
43. Pokrovskii A. The effects of the alkaloids of the sprouting potato on cholinesterase. (Russian) Biokhimiia 1956; 21: 705-10.
44. Orgell W, Vadya K, Dahm P. Inhibition of human plasma cholinesterase in vitro by extracts of solanaceous plants. Science 1958; 128: 1136-7.
45. Harris H, Whittaker M. Differential inhibition of the serum cholinesterase phenotypes by solanine and solanidine. Ann Hum Genet 1962; 26: 73-6.
46. Harris H, Whittaker M. Differential response of human serum cholinesterase types to an inhibitor in potato. Nature 1959; 183: 1808-9.
47. Patil BC, Sharma RP, Salunkhe DK, Salunkhe K. Evaluation of solanine toxicity. Food and Cosmetics Toxicology 1972; 10: 395-8.
48. Claringbold WDB, Few JD, Renwick JH. Kinetics and retention of solanidine in man. Xenobiotica 1982; 12: 293-302.
49. Matthew JA, Morgan MRA, McNerney R, Chan HW-S, Coxon DT. Determination of solanidine in human plasma by radioimmunoassay. Food Chem Toxicol 1983; 21:637-40.
50. Harvey MH, McMillan M, Morgan MRA, Chan HW-S. Solanidine is present in sera of healthy individuals and in amounts dependent on their dietary potato consumption. Hum Toxicol 1985; 4: 187-94.
51. Harvey MH, Morris BA, McMillan M, Marks V. Measurement of potato steroidal alkaloids in human serum and saliva by radioimmunoassay. Hum Toxicol 1985; 4: 503-12.
52. Swinyard CA, Chaube S. Are potatoes teratogenic for experimental animals? Teratology 1973; 8: 349-58.
53. Roddick JG. The acetylcholinesterase-inhibitory activity of steroidal glycoalkaloids and their aglycones. Phytochemistry 1989; 28: 2631-4.
54. Ehrlich G, Ginzberg D, Loewenstein Y, et al. Population diversity and distinct haplotype frequencies associated with ACHE and BCHE genes of Israeli Jews from trans-Caucasian Georgia and from Europe. Genomics 1994; 22: 288-95.
55. Neville LF, Gnatt A, Loewenstein Y, Soreq H. Aspartate-70 to glycine substitution confers resistance to naturally occurring and synthetic anionic-site ligands on in-ovo produce human butyrylcholinesterase. J Neurosci Res 1990; 27: 452-60.
56. Johns T, Alonso JG. Glycoalkaloid change during domestication of the potato, Solanum section petota. Euphytica 1990; 50: 203-10.
57. Hawkes J. History of the potato. In: PM Harris (Eds.). The Potato Crop: The Scientific Basis for Improvement. London: Chapman & Hall, 1978: 1-14.
58. Patinkin D, Seidman S, Eckstein F, Benseler F, Zakut H, Soreq H. Manipulations of cholinesterase gene expression modulate murine megakaryocytopoitesis in vitro. Mol Cell Biol 1990; 10: 6046-50.
59. Zakut H, Matzkel A, Schejter E, Avni A, Soreq H. Polymorphism of acetylcholinesterase in discrete regions of the developing human fetal brain. J Neurochem 1985; 45: 382-9.
60. Lapidot-Lifson T, Prody CA, Ginzberg D, Meytes D, Zakut H, Soreq H. Coamplification of human acetylcholinesterase and butyrylcholinesterase genes in blood cells: correlation with various leukemias and abnormal megakaryocytopoiesis. Proc Natl Acad Sci USA 1989; 86: 4715-9.
61. Zakut H, Ehrlich G, Ayalon A, et al. Acetylcholinesterase and butyrylcholinesterase genes coamplify in primary ovarian carcinomas. J Clin Invest 1990; 86: 900-8.
62. Prody CA, Dreyfus P, Zamir R, Zakut H, Soreq H. De nova amplification within a "silent" human cholinesterase gene in a family subjected to prolonged exposure to organophosphate insecticides. Proc Natl Acad Sci USA 1989; 86: 690-4.
63. Bailey DG, Spence JD, Munoz CC, Arnold JMO. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991; 337: 268-9.
64. Bushway RJ, Bureau JL, McGann DF. Alpha-chaconine and alpha-solanine content of potato peels and potato peel products. Journal of Food Science 1983; 48: 84-6.
65. Davies AMC, Blincow PJ. Glycoalkaloid content of potatoes and potato products sold in the U.K. Journal of the Science of Food and Agriculture 1984; 35: 553-7.
66. Jones PG, Fenwick GR. The glycoalkaloid content of some edible solanaceous fruits and potato products. Journal of the Science of Food and Agriculture 1981; 32:419-21.
67. Sizer CE, Maga JA, Craven CJ. Total glycoalkaloids in potatoes and potato chips. Journal of Agricultural and Food Chemistry 1980; 28: 578-9.
68. Friedman M, Dao L. Distribution of glycoalkaloids in potato plants and commercial potato products. Journal of Agricultural and Food Chemistry 1992; 40: 419-23.
69. Bushway RJ, Savage SA, Ferguson BS. Inhibition of acetylcholinesterase by solanaceous glycoalkaloids and alkaloids. American Potato Journal 1987; 64: 409-13.